Ionis Pharmaceuticals is a drugmaker company. Ionis Pharmaceuticals engages in RNA-targeted drug discovery and development, Ionis has created an efficient, broadly applicable, drug discovery platform called antisense technology that can treat diseases where no other therapeutic approaches have proven effective.

Research Grants 60 show all


$550.9K
2013

$1.9M
2014

$4.7M
2015

$86.1K
2016

$128.1K
2018

Patents 11,455show all

  • 3,394
    C12N - Microorganisms or enzymes
  • 2,986
    A61K - Preparations for medical, dental, or toilet purposes
  • 1,617
    C07H - Sugars
  • 1,351
    Y02P - Climate change mitigation technologies in the production or processing of goods
  • 1,126
    C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms
  • 933
    C07K - Peptides
  • 697
    C12Y - Enzymes
  • 625
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 312
    C07D - Heterocyclic compounds
  • 307
    C07F - Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium

Clinical Trials 201show all

80Phase 257Phase 324Phase 118N/A10Phase 1/Phase 28Other

SEC Filings show all


233
8-K

72
10-Q

18
10-K

2
D

Contact Information

2855 Gazelle Court
Carlsbad, CA 92010
United States

Overview

Total FundingEmployeesLast Funding DateStatus
$201,250,000251-5002012-08-27Ipo

Crunchbase Investment Rounds

DateAmountRoundValuationLead InvestorOther Investors
2012-08-27$201,250,000Post Ipo Debt

SEC Form D Funding Events

DateOfferedSoldType
2012-08-27$201,250,000$201,250,000Debt
2006-04-25Unknown Unknown Other (Paper Filing)

Key Executives

  • Stanley T Crooke
    Executive Officer, Director
  • Spencer R Berthelsen
    Director
  • Joseph Klein Iii
    Director
  • Frederick T Muto
    Director
  • B Lynne Parshall
    Executive Officer, Director
  • John C Reed
    Director
  • Joseph H Wender
    Director
  • C Frank Bennett
    Executive Officer
  • Richard S Geary
    Executive Officer
  • Brett P Monia
    Executive Officer